Annals of Neurology · 2003 · 405 citations · 34 references
Life SciencesNeurobiologyNeuroscienceInflammationNeurodegenerationNeuroimmunologyDrug-induced NeurotoxicityNeurodegenerative DiseasesNeurodegenerative DisordersNeuroinflammationParkinson DiseaseParkinsonian DisordersChronic NeuroinflammationDopaminergic NeurodegenerationDopaminergic Neuron DeathDopaminergic NeuronsGlial-mediated NeurotoxicityMicroglial NeuroinflammationNeuroinflammation In Parkinson DiseaseParkinsonian Degeneration
This report describes the presence of reactive microglia, the accumulation of extracellular melanin, and the extensive loss of dopaminergic neurons in the substantia nigra of monkeys administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 5 to 14 years before death. This evidence of chronic neuroinflammation years after MPTP exposure is similar to that previously reported in humans. The monkeys were drug free for at least 3 years before death, indicating that a brief exposure to MPTP had instituted an ongoing inflammatory process. The mechanism is unknown but could have important implications regarding the cause of Parkinson's disease and possible approaches to therapy.
34
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
J. William Langston, Philip L. Ballard, James W. Tetrud et al. · Science · 1983 · 4.9K citations
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Ranjita Betarbet, Todd Sherer, Gillian M. MacKenzie et al. · Nature Neuroscience · 2000 · 3.7K citations
Mitochondrial Complex I Deficiency in Parkinson's Disease
Anthony H.V. Schapira, Jonathan M. Cooper, David T. Dexter et al. · Journal of Neurochemistry · 1990 · 2.3K citations
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
Bas A. in 't Veld, Annemieke Ruitenberg, Albert Hofman et al. · New England Journal of Medicine · 2001 · 1.2K citations · Full text